Transcripts Virbac Deutsche Boerse AG

Stocks

V16

FR0000031577

Pharmaceuticals

Market Closed - Deutsche Boerse AG 09:25:02 2026-09-01 EDT			5-day change	1st Jan Change
320.50 ^EUR	+0.16%		-1.23%	-8.03%

08-20	Cancer vaccines finally garner the spotlight
07-29	Virbac, without the alibi

Transcripts

03-18	Virbac SA, 2025 Earnings Call, Mar 18, 2026
25-09-15	Virbac SA, H1 2025 Earnings Call, Sep 15, 2025
25-03-14	Virbac SA, 2024 Earnings Call, Mar 14, 2025
24-09-16	Virbac SA, H1 2024 Earnings Call, Sep 16, 2024
24-03-20	Virbac SA, 2023 Earnings Call, Mar 20, 2024
23-10-09	Virbac SA, H1 2023 Earnings Call, Oct 09, 2023
23-03-24	Virbac SA, 2022 Earnings Call, Mar 24, 2023
22-10-18	Virbac SA Provides Revenue Guidance for the Year 2022	CI
22-09-16	Virbac SA, H1 2022 Earnings Call, Sep 16, 2022
22-03-23	Virbac SA, 2021 Earnings Call, Mar 23, 2022
22-01-19	Virbac SA Provides Revenue Guidance for the Year 2022	CI
21-09-16	Virbac SA, H1 2021 Earnings Call, Sep 16, 2021
21-09-15	Virbac SA Provides Revenue Guidance for the Year 2021	CI
21-04-15	Virbac SA Revises Earnings Guidance for the Year 2021	CI
21-03-18	Virbac SA, 2020 Earnings Call, Mar 18, 2021
21-03-17	Virbac SA Provides Earnings Guidance for the Year 2021	CI
21-01-19	Virbac SA Provides Revenue Guidance for the Year 2021	CI
20-09-17	Virbac SA, H1 2020 Earnings Call, Sep 17, 2020
20-03-17	Virbac SA, 2019 Earnings Call, Mar 17, 2020
20-03-17	Virbac SA Provides Earnings Guidance for the Year 2020	CI
20-01-16	Virbac SA Announces Unaudited Consolidated Revenue Results for the Fourth Quarter and Full Year of 2019; Provides Group Revenue Guidance for the Fiscal 2020	CI
19-09-17	Virbac SA, H1 2019 Earnings Call, Sep 17, 2019
19-09-16	Virbac SA Announces Earnings Guidance for the Year 2019	CI
19-07-16	Virbac Reports Unaudited Consolidated Revenue Results for Second Quarter and Half Year Ended June 2019; Provides Revenue Guidance for the Year 2019	CI
19-03-19	Virbac SA, 2018 Earnings Call, Mar 19, 2019